Scarica l'app Stockscreener
0.483
5.62%
0.0257
Dopo l'orario di chiusura:
.53
0.047
+9.73%
Precedente Chiudi:
$0.4573
Aprire:
$0.5355
Volume 24 ore:
24.28M
Relative Volume:
0.92
Capitalizzazione di mercato:
$29.22M
Reddito:
-
Utile/perdita netta:
$-12.89M
Rapporto P/E:
-0.1909
EPS:
-2.53
Flusso di cassa netto:
$-11.95M
1 W Prestazione:
-19.03%
1M Prestazione:
+38.87%
6M Prestazione:
-61.05%
1 anno Prestazione:
-73.17%
Intervallo 1D:
$0.47
$0.5785
Intervallo di 1 settimana:
$0.45
$0.6114
Portata 52W:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Nome
Plus Therapeutics Inc
Settore
Industria
Telefono
737.255.7194
Indirizzo
4200 MARATHON BLVD., AUSTIN, TX
Confronta PSTV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.483 | 27.66M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | D. Boral Capital | Buy |
| 2021-01-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-16 | Iniziato | Maxim Group | Buy |
Plus Therapeutics Inc Borsa (PSTV) Ultime notizie
What are analysts’ price targets for Plus Therapeutics Inc. in the next 12 monthsStock Strategy Recommendation From AI Tools - jammulinksnews.com
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025 - GuruFocus
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic | PSTV Stock News - GuruFocus
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic - GlobeNewswire
Revolutionary CNS Cancer Test With 92% Accuracy Launches at Major Texas Cancer Centers - Stock Titan
Is Plus Therapeutics Inc. stock overvalued or undervaluedReal Time Watchlist With Proven Results - jammulinksnews.com
What makes Plus Therapeutics Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it
Plus Therapeutics (PSTV.O) Plunges 13%: Unpacking the Intraday Shock - AInvest
Institutional Tools Highlight Unusual Flow in Plus Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
What is the dividend policy of Plus Therapeutics Inc. stockGet daily expert analysis for smarter investing - jammulinksnews.com
Does Plus Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven investment techniques - jammulinksnews.com
Why is Plus Therapeutics Inc. stock attracting strong analyst attentionAmplify your gains with low-risk picks - jammulinksnews.com
How does Plus Therapeutics Inc. generate profit in a changing economyBoost your wealth with consistent growth stocks - jammulinksnews.com
What catalysts could drive Plus Therapeutics Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - jammulinksnews.com
How volatile is Plus Therapeutics Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
Healthcare Stocks Move in Intrday Session: Gainers and Losers - AInvest
What drives Plus Therapeutics Inc. stock priceOutstanding capital appreciation - PrintWeekIndia
What analysts say about Plus Therapeutics Inc. stockFree Stock Chart Pattern Guide - Autocar Professional
Should I buy Plus Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com
Can Plus Therapeutics Inc. stock recover from recent declineFree Consultation - jammulinksnews.com
Plus Therapeutics Skyrockets 22.22%—What’s Fueling This Volatility? - AInvest
Plus Therapeutics Soars 32.65% on $1.6M CPRIT Payment - AInvest
Why Did Plus Therapeutics (PSTV) Soar 12.24%? - AInvest
Plus Therapeutics Soars 12.65% on $17.6M CPRIT Grant for Cancer Research - AInvest
Plus Therapeutics shares rise 12.86% premarket after receiving $1.6 million advance payment from CPRIT. - AInvest
Is Plus Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Plus Therapeutics (PSTV) Secures $1.6 Million Advance from Texas Institute - GuruFocus
Plus Therapeutics Soared 22.18%—What’s Next for This Biotech Breakout? - AInvest
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant | PSTV Stock News - GuruFocus
Plus Therapeutics: Leveraging Non-Dilutive Funding to Accelerate CNS Cancer Innovation - AInvest
Plus Therapeutics Inc. Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Plus Therapeutics Announces $1.6 Million Advance Payment from CP - GuruFocus
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant - GuruFocus
Plus Therapeutics, Inc. Secures $1.6 Million Advance Payment from CPRIT to Support CNS Cancer Research and Development - Nasdaq
Plus Therapeutics receives $1.6 million advance from CPRIT grant - Investing.com
Plus Therapeutics receives $1.6 million advance from CPRIT grant By Investing.com - Investing.com UK
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT - GlobeNewswire
Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.43%
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):